Selection of CD271⁺ cells and human AB serum allows a Large expansion of mesenchymal stromal cells from human bone marrow

References

• Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 2007; 53: 121–3
   PubMed Web of Science ®Google Scholar
• Erices A, Conget P, Minguel JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235–42
   PubMed Web of Science ®Google Scholar
• De Coppi P, Bartsch G, Atala A. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotech 2006; 25: 100–6
   Web of Science ®Google Scholar
• Katz AJ, Tholpady A, Tholpady SS, et al. Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 2005; 23: 412–23
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Marrow stromal cell as stem cells for nonhemopoietic tissues. Science 1997; 276: 71–4
   PubMed Web of Science ®Google Scholar
• Caplan AL. Mesenchymal stem cells. J Orthop Res 1991; 9: 641–50
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multi-lineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
   PubMed Web of Science ®Google Scholar
• Friedestein AJ, Gorskaja JF, Kulagia NN. Fibroblast precursors in normal and irradiated mouse hemopoietic organs. Exp Hematol 1976; 4: 267–74
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–9
   PubMed Web of Science ®Google Scholar
• Villaron EM, Almeida J, Lopez-Holgado N, et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004; 89: 1421–7
   PubMed Web of Science ®Google Scholar
• Poloni A, Leoni P, Buscemi L, et al. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 2006; 20: 329–35
   Google Scholar
• Krampera M, Cosmi L, Angeli R, et al. Role of IFN-γ in the immunomodulatory activity of human mesenchymal stem cell. Stem Cells 2005; 24: 386–98
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik L, Sundberg B, et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mytogenic responses independently of the MHC. Scand J Immunol 2003; 57: 11–20
   PubMed Web of Science ®Google Scholar
• Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific cells to their cognate peptide. Blood 2003; 101: 3722–9
   PubMed Web of Science ®Google Scholar
• Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105: 2821–7
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc O, Devine SM, et al. Cotransplantation of HLA-identical sibling culture expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389–98
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–41
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Prockop D, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–13
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Further proof of the plasticity of adult stem cells and their rule in tissue repair. J Cell Biol 2003; 160: 807–9
   PubMed Web of Science ®Google Scholar
• Petite H, Viateau V, Bensaid W, et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000; 18: 959–63
   PubMed Web of Science ®Google Scholar
• Barry FP, Boynton R, Liu B, et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 2001; 268: 189–200
   PubMed Web of Science ®Google Scholar
• Quirici N, Soligo D, Bossolasco P, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002; 30: 783–91
   PubMed Web of Science ®Google Scholar
• Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. PNAS: Proc Natt Acad Sci, USA 2000; 97: 3213–18
   PubMed Web of Science ®Google Scholar
• Deans RJ, Moseley A. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875–84
   PubMed Web of Science ®Google Scholar
• Haynesworth SE, Baber M, Caplan AI. Cell surface antigens on human marrow-derived mesenchymal stem cells are detected by monoclonal antibodies. Bone 1992; 13: 69–80
   PubMed Web of Science ®Google Scholar
• Roche S, Richard MJ, Favrot MC. Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem 2006; 515: 1–10
   Google Scholar
• Sessarego N, Parodi A, Podestà A, et al. Multipotent mesenchymal stem cells from amniotic fluid: solid perspectives for clinical application. Haematologica 2008; 93: 339–46
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H, Gay R, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980; 56: 289–301
   PubMed Web of Science ®Google Scholar
• Kim J, Lee Y, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40: 75–90
   PubMed Web of Science ®Google Scholar
• Sudres M, Norol F, Trenado A, et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006; 176: 7761–7
   PubMed Web of Science ®Google Scholar
• Keyser KA, Beagles K, Kiem HP. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant 2007; 16: 555–62
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208–13
   PubMed Web of Science ®Google Scholar
• Shahdadfar A, Fronsdal K, Haug T, et al. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005; 23: 1357–66
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Samuelsson H, Lonnies L, et al. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 2007; 84: 1055–9
   PubMed Web of Science ®Google Scholar
• Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007; 25: 1270–8
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Avanzini M, Perotti C, et al. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol 2006; 211: 121–30
   Web of Science ®Google Scholar
• Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991; 78: 55–62
   PubMed Web of Science ®Google Scholar
• Deschaseaux F, Gindraux F, Saadi R, et al. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype. Br J Haematol 2003; 122: 506–17
   PubMed Web of Science ®Google Scholar
• Gindraux F, Selmani Z, Obert L, et al. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res 2007; 327: 471–83
   PubMed Web of Science ®Google Scholar
• Stewart K, Monk P, Walsh S, et al. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD166) as markers of primitive human stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tissue Res 2003; 313: 281–90
   PubMed Web of Science ®Google Scholar